DIGESTIVE CARE Are you suffering from Crohn’s disease symptoms?

Would you like to learn more about an investigational option? If so, a clinical research study for adults with moderate to severe Crohn’s disease may be for you. You may be eligible if you meet the following criteria:*



Are between the ages of 18 and 75 Are between the ages of 18 and 75

Have been diagnosed with moderately to severely

active Crohn’s disease Have been diagnosed with moderately to severelyactive Crohn’s disease



Participants will receive:



Study-related care and study drug, HUMIRA ®

(adalimumab), at no cost Study-related care and study drug,at no cost

Monitoring by the study physician and staff Monitoring by the study physician and staff



* These are only a few of the study entry criteria. Only the study doctor can determine if you are eligible to participate.

To learn more and find out if you may qualify, contact Nazia Iram at Nazia.Iram@BSWHealth.org

©2018 Baylor Scott & White Health. All rights reserved.

If this message is not displaying properly, click here to launch it in your browser.

Photography may include models or actors and may not represent actual patients. Physicians provide clinical services as members of the medical staff at one of Baylor Scott & White Health’s subsidiary, community or affiliated medical centers and do not provide clinical services as employees or agents of those medical centers or Baylor Scott & White Health. Email Marketing, Baylor Scott & White Health, 2001 Bryan St. #750, Dallas, TX 75201-3024. To change your mailing preferences or unsubscribe, click here . You may also unsubscribe by replying to this email with the word "unsubscribe" in the SUBJECT LINE.





